<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Retno Budiarti</style></author><author><style face="normal" font="default" size="100%">Ediono</style></author><author><style face="normal" font="default" size="100%">Muhammad Miftahussurur</style></author><author><style face="normal" font="default" size="100%">Abdulloh Machin</style></author><author><style face="normal" font="default" size="100%">Mochammad Wijdan Rosyich</style></author><author><style face="normal" font="default" size="100%">Ayu Imamatun Nisa</style></author><author><style face="normal" font="default" size="100%">Fatimatuzzahro</style></author><author><style face="normal" font="default" size="100%">Nila Novia Putri</style></author><author><style face="normal" font="default" size="100%">Muhammad Ja’far Shodiq</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Biomarker Profiles Associated with Covid-19 Mortality in East Java, Indonesia: A Tertiary Care Hospital Study</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Biomarker</style></keyword><keyword><style  face="normal" font="default" size="100%">COVID-19</style></keyword><keyword><style  face="normal" font="default" size="100%">Outcome</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2024</style></year><pub-dates><date><style  face="normal" font="default" size="100%">June 2024</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">16</style></volume><pages><style face="normal" font="default" size="100%">689-694</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Objective:&lt;/strong&gt; This study aimed to compare the most useful biomarkers for predicting prognosis and response to therapy in COVID-19 patients. &lt;strong&gt;Material and Methods:&lt;/strong&gt; This quantitative study involved 639 patients who were hospitalized with COVID-19 infection. Patients without any biochemical marker result; patients referred to another hospital; and peripheral oxygen levels measured using oxygen supplementation were excluded from the study. &lt;strong&gt;Results: &lt;/strong&gt;There was a statistically significant difference in terms of demographics, vital signs on admission, and laboratory parameters. The risk of mortality in COVID-19 is significantly influenced by c-reactive protein (CRP) and interleukin-6 (IL-6) levels (p-value &amp;lt;0.05). &lt;strong&gt;Conclusion:&lt;/strong&gt; Findings revealed these biomarkers could help the future development of more personalized treatment and diagnostic approaches.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">3</style></issue><work-type><style face="normal" font="default" size="100%">Research Article</style></work-type><section><style face="normal" font="default" size="100%">689</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p&gt;&lt;strong&gt;Retno Budiarti&lt;sup&gt;1&lt;/sup&gt;*, Ediono&lt;sup&gt;2&lt;/sup&gt;, Muhammad Miftahussurur&lt;sup&gt;3,4&lt;/sup&gt;, Abdulloh Machin&lt;sup&gt;5,7&lt;/sup&gt;, Wiwin Is Effendi&lt;sup&gt;5,6&lt;/sup&gt;, Mochammad Wijdan Rosyich&lt;sup&gt;7&lt;/sup&gt;, Ayu Imamatun Nisa’&lt;sup&gt;8&lt;/sup&gt;, Fatimatuzzahro’&lt;sup&gt;8&lt;/sup&gt;, Nila Novia Putri&lt;sup&gt;7&lt;/sup&gt;, Muhammad Ja’far Shodiq&lt;sup&gt;7&lt;/sup&gt;&lt;/strong&gt;&lt;/p&gt;

&lt;p&gt;&lt;sup&gt;1&lt;/sup&gt;Department of Microbiology, Faculty of Medicine, Hang Tuah University, Surabaya, INDONESIA.&lt;/p&gt;

&lt;p&gt;&lt;sup&gt;2&lt;/sup&gt;Pulmonology Department, Naval Hospital, RSAL Dr. Ramelan, Surabaya, INDONESIA.&lt;/p&gt;

&lt;p&gt;&lt;sup&gt;3&lt;/sup&gt;Division of Gastroentero-Hepatology, Department of Internal Medicine, Faculty of Medicine / Dr. Soetomo Teaching Hospital, Airlangga University, Surabaya, INDONESIA.&lt;/p&gt;

&lt;p&gt;&lt;sup&gt;4&lt;/sup&gt;Helicobacter Pylori and Microbiota Study Group, Institute of Tropical Disease, Airlangga University, Surabaya, INDONESIA.&lt;/p&gt;

&lt;p&gt;&lt;sup&gt;5&lt;/sup&gt;Infectious Hospital, Airlangga University, Surabaya, INDONESIA.&lt;/p&gt;

&lt;p&gt;&lt;sup&gt;6&lt;/sup&gt;Department of Pulmonology and Respiratory Medicine, Faculty of Medicine, Airlangga University, Surabaya&lt;/p&gt;

&lt;p&gt;&lt;sup&gt;7&lt;/sup&gt;Neurology Department, Faculty of Medicine / Dr. Soetomo Teaching Hospital, Airlangga University, Surabaya, INDONESIA.&lt;/p&gt;

&lt;p&gt;&lt;sup&gt;8&lt;/sup&gt;Faculty of Medicine, Airlangga University, Surabaya, INDONESIA.&lt;/p&gt;
</style></auth-address></record></records></xml>